Ken Griffin Neogen Corp Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$11.61 - $17.01 $17,415 - $25,515	1,500 Added 2.42%	63,400 $990,000
Q1 2024 May 15, 2024	SELL	$15.0 - $20.35 $468,000 - $634,920	-31,200 Reduced 33.51%	61,900 $976,000
Q4 2023 Feb 14, 2024	BUY	$14.65 - $20.7 $298,860 - $422,280	20,400 Added 28.06%	93,100 $1.87 Million
Q3 2023 Nov 14, 2023	SELL	$18.4 - $23.84 $577,760 - $748,576	-31,400 Reduced 30.16%	72,700 $1.35 Million
Q2 2023 Aug 14, 2023	BUY	$16.1 - $21.95 $1.03 Million - $1.4 Million	63,900 Added 158.96%	104,100 $2.26 Million
Q1 2023 May 15, 2023	SELL	$15.26 - $21.41 $93,086 - $130,601	-6,100 Reduced 13.17%	40,200 $744,000
Q4 2022 Feb 14, 2023	BUY	$10.79 - $16.56 $9,711 - $14,903	900 Added 1.98%	46,300 $705,000
Q3 2022 Nov 14, 2022	BUY	$13.97 - $24.33 $634,238 - $1.1 Million	45,400 New	45,400 $634,000

374

253M

193K

115K

Ticker NEOG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 216,108,000
Market Cap $3.73B
Description
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal f...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.